DURHAM — Levee Medical, Inc. last week filed with the SEC for their second major round of funding. According to the document the company has raised more than $3.4 million in debt from 34 investors. The company aims to raise a total of $4.3 million, with more than $850,000 remaining.

Levee Medical is focused on the development of their Voro™ Urologic Scaffold, intended to address urinary incontinence issues for patients after radical prostatectomies. According to the Levee website, the product is in the research and development phase and not yet available for sale in any country.

The company previously raised $6.6 million in a series A round last fall. Those funds were earmarked for product development and team expansion.

Durham startup targeting an implant targeting prostate cancer recovery raises $6.6M